<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01100580</url>
  </required_header>
  <id_info>
    <org_study_id>FORST-1028</org_study_id>
    <nct_id>NCT01100580</nct_id>
  </id_info>
  <brief_title>The Links Between Water and Salt Intake, Body Weight, Hypertension and Kidney Stones: a Difficult Puzzle</brief_title>
  <official_title>The Links Between Water and Salt Intake, Body Weight, Hypertension and Kidney Stones: a Difficult Puzzle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nephrolithiasis is a disease that strikes roughly 10% of the Italian population and its
      incidence in industrialized countries is on the increase. The most common form of the disease
      (80%) is Idiopathic Calcium Nephrolithiasis (ICN) with calcium-oxalate (CaOx) and/or
      calcium-phosphate (CaP) stones. The etiopathogenesis involves both genetic and acquired
      factors, the interplay of which leads to urinary biochemical anomalies at the root of stone
      formation. The elements and urinary compounds involved are known as &quot;urinary stone risk
      factors&quot;. The risk factors for CaOx stones consist of low urine volume, hypercalciuria,
      hyperoxaluria, hyperuricosuria, hypocitraturia and hypomagnesuria. In the case of CaP stones,
      the hyperphosphaturia and pH parameters are of particular importance; a pH&gt;7 promotes the
      formation of stones prevalently composed of phosphates, while a pH of between 6 and 7,
      associated with a volume &lt;1l/day, can raise CaP supersaturation to a dangerously high level
      and lead to the formation of mixed CaOx and CaP stones. For uric acid stones, the elements
      involved are hyperuricosuria and pH&lt;5.5. In general, the most prevalent alteration in ICN is
      hypercalciuria (50%). Hypertension and obesity are also social diseases with important
      epidemiological similarities to nephrolithiasis. These affinities have led to the search for
      a common pathogenic moment. As far as hypertension is concerned, various studies have
      demonstrated high calciuria in hypertensives with a linear relationship between 24-h
      calciuria and arterial blood pressure. The incidence of stone disease is greater in
      hypertensives than in normotensives and, by the same token, the incidence of hypertension is
      greater in stone formers than in non stone formers, but it is not clear whether
      nephrolithiasis is a risk factor for hypertension or vice versa. Moreover, a linear
      relationship exists between calciuria and natriuria, where the calcium is the dependent
      variable, with a much steeper slope of the straight line in stone formers and hypertensives
      compared to controls. It has, in fact, been demonstrated that to reduce calcium, it is more
      efficacious to reduce sodium intake as opposed to calcium intake. Finally, BMI and body
      weight are independently associated with an increase in stone risk even though, due to a
      number of bias (limited weight categories, low number of obese persons in the study
      populations, no control group, no recording of food intake) the studies published failed to
      be conclusive. In the final analysis, stone disease, arterial hypertension and excess
      weight/obesity prove to be closely interconnected and it is possible to intervene with
      targeted diets aimed at reducing the risk of illness and death from these diseases. Among
      such dietary approaches, the reduction of sodium chloride in food, increased hydration and an
      increased intake of foods with an alkaline potential seem to play an important role.

      For many years now, the investigators research unit has been involved in projects, partially
      financed by the Italian Ministry of University and Research (MIUR), geared towards studying
      the effects induced by dietary changes in patients with calcium stone disease. The aim of the
      present project is to analyse in depth the relationship between stone disease, hypertension,
      body weight and water and salt intake both in the general population of the area of Parma
      (where historically and by gastronomic tradition, the usual diet tends to have a high salt
      content) and in a selected population of stone formers and hypertensives not under treatment.
      A representative sample of the population of the area of Parma will be studied, divided on
      the basis of weight category, in order to assess water and salt intake and relationships with
      the presence of hypertension, and a sample of normal and hypertensive stone formers
      randomized to receive for one year either water therapy+low salt diet or water therapy alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and rationale

      Nephrolithiasis is a disease that could be defined as social, due to its widespread
      distribution and its continually increasing incidence in industrialized countries with a high
      standard of living (1). In Italy, it strikes just under 10% of the population, leading to
      expenditure of approx. 200 million euro/year for hospital admissions alone (2). Idiopathic
      Calcium Nephrolithiasis (ICN) with the formation of calcium oxalate stones, sometimes mixed
      with calcium phosphate ones, is the most common form, having an incidence of roughly 80%
      (3,4). As regards distribution in the two sexes, a slightly higher incidence in males has
      been observed. The pathogenesis of ICN involves both genetic and acquired factors (5), the
      combining of which leads to urinary biochemical anomalies which lie at the root of stone
      formation. A high rate of calcium-oxalate and/or calcium-phosphate supersaturation leads to
      the formation of nests of crystals that can then grow and aggregate to form a stone. The
      elements and urine compounds involved in the process of crystallization, whether they be
      inhibitors or promoters, are known as urinary stone risk factors. For Ca-oxalate they are:
      low urine volume (&lt;2 l/day), hypercalciuria (&gt;250mg/day), hyperoxaluria (&gt;40 mg/day),
      hyperuricosuria (&gt;600 mg/day), hypocitraturia (&lt;320 mg/day) and hypomagnesuria (&lt;50 mg/day).
      For Ca-phosphate, in addition to the above-mentioned factors, hyperphosphaturia (&gt;1000
      mg/day) and urinary pH also acquire considerable importance: a pH&gt;7 promotes the formation of
      stones prevalently composed of phosphates, while a pH of between 6 and 7 associated with a
      urine volume &lt;1l/day, can dangerously raise Ca-phosphate supersaturation and lead to the
      formation of mixed Ca-oxalate and Ca-phosphate stones. Finally, for uric acid stone disease
      the elements involved are hyperuricosuria and pH &lt; 5.5. Among the stone risk factors, the
      most common found in the urine of patients affected by ICN is hypercalciuria with an
      incidence of around 50%. With regard to age of onset, there are two peaks, one between 20 and
      30 years of age and one between 50 and 60.

      Hypertension and obesity are also widespread social diseases with important epidemiological
      similarities to nephrolithiasis. These affinities have, over the years, led investigators to
      seek interconnections between the three diseases in order to find a common pathogenic moment.
      As far as hypertension is concerned, various studies have demonstrated that urinary excretion
      of calcium is greater in hypertensives than in normotensives. A linear association between
      the excretion of 24-h calcium and arterial blood pressure has been demonstrated in numerous
      studies, including INTERSALT (6). In 1999, after following up 132 hypertensives and 135
      controls for 5 years, our group published a paper which reported the onset of stone disease
      in the hypertensives in significantly higher percentages compared to the controls, with an RR
      of 5.5 (7). Moreover, a year earlier, Madore and Curhan published two studies (8,9) conducted
      on a large cohort of Americans in which they demonstrated that patients with a past history
      of nephrolithiasis without hypertension were more prone to become hypertensive during the
      follow-up than non stone formers. These results, further confirmed by many subsequent
      studies, did not however succeed in clarifying the doubt as to whether it is the
      hypercalciuria of hypertensives that predisposes them to the development of stone disease or
      whether it is the renal damage, albeit microscopic, caused by stone disease that triggers the
      development of hypertension. Scientific literature has, however, identified, for
      hypertensives, stone formers and controls alike, a linear relationship between the excretion
      of calcium and the excretion of sodium, where calcium is the dependent variable and where the
      slope of the straight line, i.e. the increase of calcium for each mmol of sodium, is much
      greater in both stone formers and hypertensives than in controls. Moreover, as far back as
      the '80s, it was demonstrated that a reduction in kitchen salt intake from 10 g to 4 g per
      day, has the capacity to reduce calciuria more than a reduction in calcium intake from 1000
      mg to 500 mg (10,11).

      In 2002, we confirmed this experimental data with a paper published in the New England
      Journal of Medicine in which we demonstrated in recurrent male hypercalciuric stone formers
      followed up for 5 years, that a normal calcium, low-salt, low-protein diet had the power to
      reduce both the calciuria and the stone recurrences much more significantly than a
      low-calcium diet (12). Obviously it was not possible to separate the effect of the
      restriction of sodium from the restriction of protein. Both diets were accompanied by the
      recommendation to drink water, the effectiveness of which had already been demonstrated in
      first-episode stone formers in a previous study randomized with a follow-up of 5 years
      conducted on 199 stone formers and 101 controls (13).

      The central role of body weight in determining stone risk is clearly described in scientific
      literature. BMI, weight, abdominal circumference are independently associated with kidney
      stone risk (14). Nevertheless, the mechanisms underlying this relation are still unknown.
      Data exist in literature to suggest that body weight can affect the excretion of many
      promoters or inhibitors of crystalline aggregation. For example, some population studies in
      the United States have demonstrated how urine pH is inversely correlated to body weight and
      how urinary excretion of calcium, oxalate and uric acid increase as body weight increases
      (15,16). Notwithstanding these data, the effects of body weight on the excretion of many
      urinary stone risk factors remains partly unknown; this is due to the limited weight
      categories, the low number of obese people in the study populations, the absence of a control
      group with &quot;non stone formers&quot; and the failure to record food intake in the studies
      published. In addition to this, as regards urinary excretion, the evaluation of excess weight
      solely on the basis of BMI values and abdominal circumference may seem somewhat reductive. It
      would appear to be more useful to assess body composition, lean mass, fat tissue mass and
      mineral mass. In this way, by better stratifying obesity classes, it might become simpler to
      understand the intricate endocrine/metabolic changes that occur in obesity (hyperinsulinism,
      hyperestrogenism etc.) and establish better correlations with the urinary excretion of stone
      risk factors. In fact, some studies (16) have demonstrated a slight increase in the total
      incidence of stone disease in female obese patients compared to males, with a slightly higher
      mean age in the females and, in any case, ages being equal, with a lower number of
      recurrences in the females compared to the males. These phenomena are probably affected by
      the concentration of serum estrogens and by the transformation in the fatty tissue of the
      adrenal androgens into estrogens; nonetheless the effects of serum estrogens on the urinary
      excretion of calcium are unknown. Finally, some studies have demonstrated that body weight
      also affects the composition of the stones. In fact, it has been demonstrated how the
      incidence of uric acid stones is higher in overweight/obese patients than in normal weight
      patients; some studies have highlighted that patients with idiopathic uric acid
      nephrolithiasis have a higher BMI than hyperuricosuric patients who form calcium oxalate
      stones. The pathophysiological link should be sought in hyperinsulinism: in fact insulin
      resistance is associated with a decrease in the production of renal ammonia leading to a
      consequent decrease in urinary pH, characteristic of uric acid stone disease (17). This
      theory is indirectly corroborated by the aforementioned indirect relationship between BMI and
      24-h urine pH and the finding that also age-related reduced urinary acidification capacity
      increases the risk of uric stone disease, irrespective of body weight. On the basis of the
      above, it is clear how the presence of excess weight/obesity, uric acid or mixed stone
      disease could raise suspicions of a Metabolic Syndrome: there are, however, no conclusive
      studies on this, and neither have the effects on stone risk and arterial blood pressure of
      water therapy and a low-salt diet in a population of overweight/obese stone formers been
      sufficiently studied.

      In the final analysis, nephrolithiasis, arterial hypertension and excess weight/obesity prove
      to be closely interconnected and it is possible to develop targeted diets aimed at reducing
      the risk of illness and death from this disease. Among such dietary approaches, the reduction
      of sodium chloride in food, increased hydration and an increased intake of foods with an
      alkaline potential (18) seem to play an important role.

      For many years now, our research unit has been involved in projects, partially financed by
      the Italian Ministry of University and Research (MIUR), geared towards studying the effects
      induced by dietary changes in patients with calcium stone disease. The aim of the present
      project is to deepen our knowledge on the relationship between stone disease, hypertension,
      body weight and water and salt intake both in the general population of the area of Parma,
      where historically and by gastronomic tradition the normal diet tends to have a high salt
      content, and in a selected population of stone formers and hypertensives.

      Experimental design/description of methodologies

      As already mentioned, the aim of this project is to attempt to clarify the relationship
      between idiopathic calcium stone disease, salt and water intake, hypertension and body
      weight.

      The study will be divided into two sub-projects:

        1. Assessment of the salt and water intake in the general population of the area of Parma
           (duration 24 months)

        2. Assessment of the effects of a low salt + water therapy diet vs water therapy alone for
           one year in patients with idiopathic calcium stone disease, both male and female,
           normal- and hypertensive without treatment (duration 12 months)

      At least 350 healthy controls, 100 hypertensive non stone formers without treatment, 150
      normotensive stone formers and 100 hypertensive stone formers without treatment will be
      enrolled in the study. Both the controls and the stone formers will be subdivided according
      to a 4-class BMI scale. The classes will have the following characteristics: Class 1 BMI Â£
      18.9 (underweight condition); Class 2 BMI between 19 and 24.9 (normal weight condition);
      Class 3 BMI between 25 and 29.9 (excess weight condition); Class 4 BMI &gt; 30 (obesity). The
      patients enrolled will have their medical history recorded after which they will be subjected
      to the measurement of anthropometric parameters and arterial blood pressure, and a stone risk
      mini-profile will be drawn up including volume, creatinine, sodium, potassium and calcium
      measured according to the methods published. As is well-known, 24-h urinary sodium is
      considered the &quot;gold standard&quot; for the assessment of food-related salt intake, creatinine is
      a sensitive marker of lean mass, potassium is an index of the body's alkaline potential and
      calcium has the important pathophysiological role described above.

      The stone formers will be randomized to receive a low salt+water therapy diet or water
      therapy alone, for one year. The term &quot;water therapy&quot; refers to an abundant intake of water
      with a low mineral and low sodium content (at least 2 litres in winter and 3 in summer). For
      stone formers only, at the end of the 12 month period of therapy, anthropometric parameters
      and arterial blood pressure will be measured once more and the urinary mini-profile will be
      repeated.

      Objectives

      Sub-project 1) &quot;Assessment of the salt and water intake in the general population of the area
      of Parma&quot;

      Primary objective To assess the consumption of kitchen salt (NaCl) and the water intake in
      the general population of the area of Parma after adjustment for the BMI, and to study any
      possible relationships with the presence of arterial hypertension.

      Secondary objectives

        1. To study the urinary sodium-calcium relationship in the general normo- and hypertensive
           population without treatment.

        2. To confirm the described relationship between 24-h calciuria and arterial blood
           pressure.

        3. To identify any correlations between BMI and urinary solutes.

        4. To stratify the salt and water intake by age category.

        5. To assess the stone risk in the general normo- and hypertensive population without
           treatment.

        6. To define urinary sodium-potassium-volume relationships in the general normo- and
           hypertensive population without treatment.

      Sub-project 2) &quot;Assessment of the effects of a low salt + water therapy diet vs water therapy
      alone for one year in patients with idiopathic calcium stone disease, both male and female,
      normal- and hypertensive without treatment (duration 12 months)&quot;

      Primary objective To assess the effects of a low-salt diet + water therapy vs water therapy
      alone, maintained for one year, on calciuria, arterial blood pressure and body weight in
      normo- and hypertensive stone formers.

      Secondary objectives

        1. To study the urinary sodium-calcium relationship in normo- and hypertensive stone
           formers without treatment and compare it with matched non stone formers.

        2. To study the relationship between 24-h calciuria and arterial blood pressure in stone
           formers and compare it with matched non stone formers.

        3. To identify any correlations between BMI and urinary solutes and evaluate the
           differences with matched non stone formers.

        4. To stratify the salt and water intake by age category and recurrence rate in recurrent
           stone formers.

        5. To assess the compliance with the low salt diet after one year.

        6. To define the urinary sodium-potassium-volume relationships in normo- and hypertensive
           stone formers without treatment and compare them with matched non stone formers.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">May 2012</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>normalization of urinary stone risk factors</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>urinary sodium/calcium relationship</measure>
    <time_frame>one yaer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure reduction</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>relationship between 24h-calciuria and blood pressure</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stone rate reduction</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation BMI-urinary stone risk factors</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>compliance</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Urinary Stones</condition>
  <condition>Hypertension</condition>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>water therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The term &quot;water therapy&quot; refers to an abundant intake of water with a low mineral and low sodium content (at least 2 litres in winter and 3 in summer).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low salt diet + water therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low salt diet refers to a salt intake of 4 g/day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low salt diet</intervention_name>
    <description>Daily salt intake less than 4 g/day</description>
    <arm_group_label>low salt diet + water therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>water therapy</intervention_name>
    <description>abundant intake of water with a low mineral and low sodium content (at least 2 litres in winter and 3 in summer).</description>
    <arm_group_label>water therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For the stone formers main inclusion criteria

          -  age between 20 and 70 years

          -  caucasian race

          -  idiopathic calcium stone disease

          -  normal renal function (creatininemia &lt;1.2 mg/dl)

        Main exclusion criteria

          -  other major diseases

          -  diseases affecting the mineral and electrolyte metabolism (diabetes, endocrine
             diseases, inflammatory diseases etc.)

          -  treatments affecting the mineral and electrolytic metabolism (vitamin D,
             acetazolamide, anti-epilectic drugs, steroids etc).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loris Borghi, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Parma</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Loris Borghi, Prof</last_name>
    <phone>+390521703375</phone>
    <email>loris.borghi@unipr.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Parma</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loris Borghi, Prof</last_name>
      <phone>+390521703375</phone>
      <email>loris.borghi@unipr.it</email>
    </contact>
    <investigator>
      <last_name>Loris Borghi, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int. 2003 May;63(5):1951-2. Review.</citation>
    <PMID>12675877</PMID>
  </reference>
  <reference>
    <citation>Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ. 1996 May 18;312(7041):1249-53. Erratum in: BMJ 1997 Aug 23;315(7106):458.</citation>
    <PMID>8634612</PMID>
  </reference>
  <reference>
    <citation>Goulding A, McParland BE. Fasting and 24-h urinary sodium/creatinine values in young and elderly women on low-salt and salt-supplemented regimens. J Cardiovasc Pharmacol. 1990;16 Suppl 7:S47-9.</citation>
    <PMID>1708023</PMID>
  </reference>
  <reference>
    <citation>Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002 Jan 10;346(2):77-84.</citation>
    <PMID>11784873</PMID>
  </reference>
  <reference>
    <citation>Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005 Jan 26;293(4):455-62.</citation>
    <PMID>15671430</PMID>
  </reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2010</study_first_submitted>
  <study_first_submitted_qc>April 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2010</study_first_posted>
  <last_update_submitted>April 8, 2010</last_update_submitted>
  <last_update_submitted_qc>April 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Loris Borghi</name_title>
    <organization>University of Parma</organization>
  </responsible_party>
  <keyword>Low-salt diet</keyword>
  <keyword>calciuria</keyword>
  <keyword>blood pressure</keyword>
  <keyword>nephrolithiasis</keyword>
  <keyword>hypertension</keyword>
  <keyword>BMI</keyword>
  <keyword>urinary stone risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

